Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D02NJV
|
||||
| Former ID |
DNC004754
|
||||
| Drug Name |
Des-AA1,2,5,12,13-[D-Trp8,IAmp9]SRIF
|
||||
| Indication | Discovery agent | Investigative | [527385] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C67H84N12O11S2
|
||||
| Canonical SMILES |
CC(C)NCC1=CC=C(C=C1)CC2C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(<br />=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC3=CNC4=CC=CC=C4<br />3)CC5=CC=CC=C5)CC6=CC=CC=C6)CCCCN)N)C(=O)O)CC7=CC=CC=C7<br />)C(C)O
|
||||
| InChI |
1S/C67H84N12O11S2/c1-40(2)70-36-46-28-26-45(27-29-46)34-55-65(87)79-58(41(3)80)66(88)77-54(33-44-21-11-6-12-22-44)63(85)78-57(67(89)90)39-92-91-38-49(69)59(81)72-51(25-15-16-30-68)60(82)73-52(31-42-17-7-4-8-18-42)61(83)74-53(32-43-19-9-5-10-20-43)62(84)76-56(64(86)75-55)35-47-37-71-50-24-14-13-23-48(47)50/h4-14,17-24,26-29,37,40-41,49,51-58,70-71,80H,15-16,25,30-36,38-39,68-69H2,1-3H3,(H,72,81)(H,73,82)(H,74,83)(H,75,86)(H,76,84)(H,77,88)(H,78,85)(H,79,87)(H,89,90)/t41-,49-,51-,52-,53+,54+,55+,56+,57+,58-/m1/s1
|
||||
| InChIKey |
CRBKELXXBMEXSB-BHKHLLRWSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Somatostatin receptor type 3 | Target Info | Inhibitor | [527385] | |
| Somatostatin receptor 1 | Target Info | Inhibitor | [527385] | ||
| Somatostatin receptor type 4 | Target Info | Inhibitor | [527385] | ||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
| Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
| PathWhiz Pathway | Gastric Acid Production | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.